{"product_id":"new-product-633178","title":"Mini Samples ELISA Kit for Creatine Kinase MB Isoenzyme (CKMB)","description":"\u003cp\u003eEnzyme-linked immunosorbent assay for Antigen Detection.\u003c\/p\u003e\n\u003cp\u003eProduct No.\u003c\/p\u003e\n\u003cp\u003eMEA479Mu\u003c\/p\u003e\n\u003cp\u003eOrganism Species\u003c\/p\u003e\n\u003cp\u003eMus musculus (Mouse).\u003c\/p\u003e\n\u003cp\u003eSample Type\u003c\/p\u003e\n\u003cp\u003eSerum, plasma, tissue homogenates and other biological fluids\u003c\/p\u003e\n\u003cp\u003eTest Method\u003c\/p\u003e\n\u003cp\u003eDouble-antibody Sandwich\u003c\/p\u003e\n\u003cp\u003eAssay Length\u003c\/p\u003e\n\u003cp\u003e3h\u003c\/p\u003e\n\u003cp\u003eDetection Range\u003c\/p\u003e\n\u003cp\u003e0.78-50ng\/mL\u003c\/p\u003e\n\u003cp\u003eSensitivity\u003c\/p\u003e\n\u003cp\u003eThe minimum detectable dose of this kit is typically less than 0.34ng\/mL.\u003c\/p\u003e\n\u003cp\u003eUOM\u003c\/p\u003e\n\u003cp\u003e48T 96T 96T*5 96T*10 96T*100\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch3\u003eSpecificity\u003c\/h3\u003e\n\u003cdiv\u003e\n\u003cp\u003eThis assay has high sensitivity and excellent specificity for detection of Mini Samples Creatine Kinase MB Isoenzyme (CKMB).\u003cbr\u003eNo significant cross-reactivity or interference between Mini Samples Creatine Kinase MB Isoenzyme (CKMB) and analogues was observed.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003ch3\u003eRecovery\u003c\/h3\u003e\n\u003cdiv\u003e\n\u003cp\u003eMatrices listed below were spiked with certain level of recombinant Mini Samples Creatine Kinase MB Isoenzyme (CKMB) and the recovery rates were calculated by comparing the measured value to the expected amount of Mini Samples Creatine Kinase MB Isoenzyme (CKMB) in samples.\u003c\/p\u003e\n\u003ctable\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eMatrix\u003c\/td\u003e\n\u003ctd\u003eRecovery range (%)\u003c\/td\u003e\n\u003ctd\u003eAverage(%)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eserum(n=5)\u003c\/td\u003e\n\u003ctd\u003e87-96\u003c\/td\u003e\n\u003ctd\u003e92\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEDTA plasma(n=5)\u003c\/td\u003e\n\u003ctd\u003e83-92\u003c\/td\u003e\n\u003ctd\u003e88\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eheparin plasma(n=5)\u003c\/td\u003e\n\u003ctd\u003e82-89\u003c\/td\u003e\n\u003ctd\u003e85\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003ch3\u003ePrecision\u003c\/h3\u003e\n\u003cdiv\u003e\n\u003cp\u003eIntra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Mini Samples Creatine Kinase MB Isoenzyme (CKMB) were tested 20 times on one plate, respectively.\u003cbr\u003eInter-assay Precision (Precision between assays): 3 samples with low, middle and high level Mini Samples Creatine Kinase MB Isoenzyme (CKMB) were tested on 3 different plates, 8 replicates in each plate.\u003cbr\u003eCV(%) = SD\/meanX100\u003cbr\u003eIntra-Assay: CV\u0026lt;10%\u003cbr\u003eInter-Assay: CV\u0026lt;12%\u003cbr\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003ch3\u003eLinearity\u003c\/h3\u003e\n\u003cdiv\u003e\n\u003cp\u003eThe linearity of the kit was assayed by testing samples spiked with appropriate concentration of Mini Samples Creatine Kinase MB Isoenzyme (CKMB) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.\u003c\/p\u003e\n\u003ctable\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eSample\u003c\/td\u003e\n\u003ctd\u003e1:2\u003c\/td\u003e\n\u003ctd\u003e1:4\u003c\/td\u003e\n\u003ctd\u003e1:8\u003c\/td\u003e\n\u003ctd\u003e1:16\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eserum(n=5)\u003c\/td\u003e\n\u003ctd\u003e96-105%\u003c\/td\u003e\n\u003ctd\u003e93-103%\u003c\/td\u003e\n\u003ctd\u003e81-102%\u003c\/td\u003e\n\u003ctd\u003e85-94%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEDTA plasma(n=5)\u003c\/td\u003e\n\u003ctd\u003e99-105%\u003c\/td\u003e\n\u003ctd\u003e87-94%\u003c\/td\u003e\n\u003ctd\u003e82-90%\u003c\/td\u003e\n\u003ctd\u003e86-97%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eheparin plasma(n=5)\u003c\/td\u003e\n\u003ctd\u003e90-102%\u003c\/td\u003e\n\u003ctd\u003e79-93%\u003c\/td\u003e\n\u003ctd\u003e99-105%\u003c\/td\u003e\n\u003ctd\u003e80-96%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003ch3\u003eStability\u003c\/h3\u003e\n\u003cdiv\u003e\n\u003cp\u003eThe stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.\u003cbr\u003eTo minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003ch3\u003eReagents and materials provided\u003c\/h3\u003e\n\u003cdiv\u003e\n\u003cdiv class=\"reagent_div\"\u003e\n\u003ctable class=\"reagent_table\"\u003e\n\u003ctbody\u003e\n\u003ctr class=\"first_tr\"\u003e\n\u003ctd\u003eReagents\u003c\/td\u003e\n\u003ctd\u003eQuantity\u003c\/td\u003e\n\u003ctd\u003eReagents\u003c\/td\u003e\n\u003ctd\u003eQuantity\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePre-coated, ready to use 96-well strip plate\u003c\/td\u003e\n\u003ctd\u003e1\u003c\/td\u003e\n\u003ctd\u003ePlate sealer for 96 wells\u003c\/td\u003e\n\u003ctd\u003e4\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eStandard\u003c\/td\u003e\n\u003ctd\u003e2\u003c\/td\u003e\n\u003ctd\u003eStandard Diluent\u003c\/td\u003e\n\u003ctd\u003e1×20mL\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDetection Reagent A\u003c\/td\u003e\n\u003ctd\u003e1×60µL\u003c\/td\u003e\n\u003ctd\u003eAssay Diluent A\u003c\/td\u003e\n\u003ctd\u003e1×6mL\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDetection Reagent B\u003c\/td\u003e\n\u003ctd\u003e1×60µL\u003c\/td\u003e\n\u003ctd\u003eAssay Diluent B\u003c\/td\u003e\n\u003ctd\u003e1×6mL\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTMB Substrate\u003c\/td\u003e\n\u003ctd\u003e1×4.5mL\u003c\/td\u003e\n\u003ctd\u003eStop Solution\u003c\/td\u003e\n\u003ctd\u003e1×3mL\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWash Buffer (30 × concentrate)\u003c\/td\u003e\n\u003ctd\u003e1×10mL\u003c\/td\u003e\n\u003ctd\u003eInstruction manual\u003c\/td\u003e\n\u003ctd\u003e1\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003ch3\u003eAssay procedure summary\u003c\/h3\u003e\n\u003cdiv\u003e\n\u003cp\u003e1. Prepare all reagents, samples and standards;\u003cbr\u003e2. Add 25µL standard or sample to each well. Incubate 1 hour at 37°C;\u003cbr\u003e3. Aspirate and add 25µL prepared Detection Reagent A. Incubate 1 hour at 37°C;\u003cbr\u003e4. Aspirate and wash 3 times;\u003cbr\u003e5. Add 25µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;\u003cbr\u003e6. Aspirate and wash 5 times;\u003cbr\u003e7. Add 25µL Substrate Solution. Incubate 10-20 minutes at 37°C;\u003cbr\u003e8. Add 20µL Stop Solution. Read at 450nm immediately.\u003c\/p\u003e\n\u003cp\u003eMagazine Citations\u003cbr\u003eCardiovascular Toxicology Aldehyde Dehydrogenase-2 Activation during Cardioplegic Arrest Enhances the Cardioprotection against Myocardial Ischemia–Reperfusion Injury PubMed: 22814936\u003cbr\u003ePLoS One N-Acetylcysteine and Allopurinol Confer Synergy in Attenuating Myocardial Ischemia Injury via Restoring HIF-1α\/HO-1 Signaling in Diabetic Rats PubMed: PMC3715528\u003cbr\u003eInt J Clin Exp Med Effects of morphine and sufentanil preconditioning against myocardial ischemic-reperfusion injury in rabbits PubMed: 26629064\u003cbr\u003eEuropean Journal of Pharmacology Diabetes blocks the cardioprotective effects of sevoflurane postconditioning by impairing Nrf2\/Brg1\/HO-1 signaling Pubmed:26973173\u003cbr\u003eAsian Pac J Trop Med. Effect of levocarnitine on TIMP-1, ICAM-1 expression of rats with coronary heart disease and its myocardial protection effect Pubmed:26972400\u003cbr\u003eHeart International Circulating miR-126 and miR-499 reflect progression of cardiovascular disease; correlations with uric acid and ejection fraction pubmed:27924211\u003cbr\u003eAmerican Journal of Translational Research Peroxisome proliferator-activated receptor γ (PPARγ) mediates the protective effect of quercetin against myocardial ischemia-reperfusion injury via … PMC5209473\u003cbr\u003eArchivum Immunologiae et Therapiae Experimentalis In Vivo Cardioprotective Effects and Pharmacokinetic Profile of N-Propyl Caffeamide AgainstIschemia Reperfusion Injury. pubmed:27480649\u003cbr\u003eArchivos de medicina veterinaria Cardiac biomarkers in dogs with visceral leishmaniasis S0301-732X2016000300004\u003cbr\u003eCellular Physiology and Biochemistry Remote Limb Ischaemic Postconditioning Protects Against Myocardial Ischaemia\/ Reperfusion Injury in Mice: Activation of JAK\/STAT3-Mediated Nrf2-Antioxidant Signalling 10.1159:481755\u003cbr\u003eErciyes Medical Journal Morinda Citrifolia (Noni) and Low Dose Aspirin Prevent Apoptotic Cell Death and Oxidative Stress on Isoproterenol Induced Myocardial Infarction in Rats DOI: 10.5152\/etd.2017.1732\u003cbr\u003eInternational Immunopharmacology Metformin attenuated endotoxin-induced acute myocarditis via activating AMPK pubmed:28410530\u003cbr\u003eScience of the Total Environment Co-exposure of silica nanoparticles and methylmercury induced cardiac toxicity and Pubmed:29727991\u003cbr\u003eJournal of Surgical Research GYY4137 protects against myocardial ischemia\/reperfusion injury via activation of the PHLPP-1\/Akt\/Nrf2 signaling pathway in diabetic mice Pubmed:29605032\u003cbr\u003eMolecular Medicine Reports Hydrogen‑rich solution against myocardial injury and aquaporin expression via the PI3K\/Akt signaling pathway during cardiopulmonary bypass in rats Pubmed:29956781\u003cbr\u003eCell Death Discovery Cyclic helix B peptide ameliorates acute myocardial infarction in mice by inhibiting apoptosis and inflammatory responses\u003cbr\u003eOxidative Medicine and Cellular Longevity Adiponectin Facilitates Postconditioning Cardioprotection through Both AMPK-Dependent Nuclear and AMPK-Independent Mitochondrial STAT3 Activation Pubmed: 32190173\u003cbr\u003ePLoS One Tissue suction-mediated gene transfer to the beating heart in mice Pubmed: 32027678\u003cbr\u003eFASEB JOURNAL Deletion of Rap1 protects against myocardial ischemia\/reperfusion injury through suppressing cell apoptosis via activation of STAT3 signaling Pubmed: 32020680\u003cbr\u003eMolecular Medicine Reports Differentially expressed lncRNAs, miRNAs and mRNAs with associated ceRNA networks in a mouse model of myocardial ischemia\/reperfusion injury Pubmed: 32705277\u003cbr\u003eIn Vivo Hydrogen sulphide and nitric oxide cooperate in cardioprotection against ischemia\/reperfusion injury in isolated rat heart Pubmed: 32871779\u003cbr\u003eDrug Design Development and Therapy Melatonin Attenuates Anoxia\/Reoxygenation Injury by Inhibiting Excessive Mitophagy Through the MT2\/SIRT3\/FoxO3a Signaling Pathway in H9c2 Cells Pubmed: 32546969\u003cbr\u003eNanomaterials Biological Safety and Biodistribution of Chitosan Nanoparticles Pubmed: 32340313\u003cbr\u003eMolecular Medicine Reports The mRNA expression of Il6 and Pdcd1 are predictive and protective factors for doxorubicin?induced cardiotoxicity 33300057\u003cbr\u003eOxid Med Cell Longev Inactivation of TOPK Caused by Hyperglycemia Blocks Diabetic Heart Sensitivity to Sevoflurane Postconditioning by Impairing the PTEN\/PI3K\/Akt Signaling 33986917\u003cbr\u003eEur J Pharmacol Long non-coding RNA MALAT1 modulates myocardial ischemia-reperfusion injury though the PI3K\/Akt\/eNOS pathway by sponging miRNA-133a-3p to target IGF1R … Pubmed:34968461\u003cbr\u003eCardiovasc Drugs Ther Hyperglycemia-Induced Overexpression of PH Domain Leucine-Rich Repeat Protein Phosphatase 1 (PHLPP1) Compromises the Cardioprotective Effect of Ischemic … Pubmed:35715527\u003cbr\u003eNutrients Mokko Lactone Alleviates Doxorubicin-Induced Cardiotoxicity in Rats via Antioxidant, Anti-Inflammatory, and Antiapoptotic Activities. Nutrients 2022, 14, 733 Pubmed:35215383\u003cbr\u003eExperimental and Therapeutic Medicine Hydrogen therapy after resuscitation improves myocardial injury involving inhibition of autophagy in an asphyxial rat model of cardiac arrest Pubmed:35495584\u003cbr\u003eOxidative Medicine and Cellular Longevity MicroRNA-503 Exacerbates Myocardial Ischemia\/Reperfusion Injury via Inhibiting PI3K\/Akt-and STAT3-Dependent Prosurvival Signaling Pathways Pubmed:35620576\u003cbr\u003eInternational Journal of Sciences: Basic and Applied Research Vitamin E Attenuates Cardiomyopathy Via Alleviation of Autophagic Stress\u003cbr\u003eCatalog No. Related products for research use of Mus musculus (Mouse) Organism species Applications (RESEARCH USE ONLY!)\u003cbr\u003eSEA479Mu ELISA Kit for Creatine Kinase MB Isoenzyme (CKMB) Enzyme-linked immunosorbent assay for Antigen Detection.\u003cbr\u003eMEA479Mu Mini Samples ELISA Kit for Creatine Kinase MB Isoenzyme (CKMB) Enzyme-linked immunosorbent assay for Antigen Detection.\u003cbr\u003eLMA479Mu Magnetic Luminex Assay Kit for Creatine Kinase MB Isoenzyme (CKMB) ,etc. Magnetic Luminex Assay for Antigen Detection.\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Cloud-clone","offers":[{"title":"96T \/ The minimum detectable dose of this kit is typically less than 0.34ng\/mL \/ 0.78-50ng\/mL","offer_id":47582548820248,"sku":"MEA479Mu","price":691.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0590\/5652\/1400\/products\/SE_BIG_518a039f-794c-448e-9f5b-e99847846c1a.jpg?v=1706135849","url":"https:\/\/danabiosci.com\/products\/new-product-633178","provider":"Dana Bioscience","version":"1.0","type":"link"}